Fabry disease synonyms

TL;DR: Fabry disease is primarily known as Anderson-Fabry disease or alpha-galactosidase A deficiency. While historical literature may refer to it as angiokeratoma corporis diffusum, "Fabry disease" remains the standard clinical term used by medical professionals and researchers today.

Why does Fabry disease have multiple names?

The naming of Fabry disease reflects its discovery in 1898 by two independent dermatologists, Johannes Fabry and William Anderson, who both described the characteristic skin lesions now known as angiokeratomas. Over the decades, as the underlying metabolic mechanism—a deficiency of the enzyme alpha-galactosidase A—was identified, the medical community shifted from descriptive names based on physical symptoms to names based on the biochemical cause. Today, Fabry disease is the preferred designation, as it honors the original clinical descriptions while remaining concise for modern diagnostic and electronic health record systems.

What are the historical and clinical synonyms for Fabry disease?

Patients may encounter various terms in older medical records, research papers, or international literature. Understanding these synonyms is crucial when researching Fabry disease or reviewing historical clinical notes. Common alternative designations include:

• Anderson-Fabry disease: A dual-eponym that acknowledges both primary discoverers.


• Alpha-galactosidase A deficiency: The most precise biochemical name, identifying the root cause of the lysosomal storage disorder.


• Angiokeratoma corporis diffusum: A descriptive historical term referring to the widespread skin manifestations; this is rarely used as a primary diagnosis today.


• GLA deficiency: An abbreviation referring to the GLA gene mutation responsible for the condition.


• Hereditary dystopic lipidosis: An older, less common term used to describe the nature of the metabolic lipid accumulation.

How is Fabry disease classified in medical databases?

Standardized classification systems use specific codes to ensure accurate tracking and research. In the International Classification of Diseases (ICD-10/11), Fabry disease is categorized under lysosomal storage disorders. Researchers and geneticists typically refer to the Online Mendelian Inheritance in Man (OMIM) entry #301500 to identify the specific genetic variants associated with the condition. Furthermore, Orphanet classifies the condition under the identifier ORPHA:324, providing a standardized international reference that helps patients and clinicians locate specialized care across different healthcare systems.

Is the name Fabry disease used globally?

Yes, Fabry disease is the universally accepted term in clinical practice, medical literature, and patient advocacy. While some European medical traditions historically leaned toward "Anderson-Fabry disease," the simplification to Fabry disease has been widely adopted for consistency. At DiseaseMaps.org, we have seen 174 members join our community specifically under the name Fabry disease, demonstrating that this is the primary identity used by those living with the condition to connect, share experiences, and seek support.

Next steps

• Consult a genetic counselor or a metabolic specialist to confirm your specific genetic variant and how it is documented in your records.


• If you are searching medical literature, use the term "Fabry disease" combined with "GLA deficiency" to ensure you retrieve the most relevant clinical studies.


• Join the 174-member community on DiseaseMaps.org to share your experiences and learn how others navigate the healthcare system with this diagnosis.


• Ensure your primary care physician uses the official ICD code for Fabry disease to facilitate proper insurance coverage and specialist referrals.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Fabry disease.


• Orphanet: Rare disease database, ORPHA:324 (Fabry disease).


• OMIM (Online Mendelian Inheritance in Man): Entry #301500, Alpha-galactosidase A deficiency.


• National Fabry Disease Foundation: Educational resources and clinical guidelines.